Provided by Tiger Trade Technology Pte. Ltd.

Ashland

73.71
+1.051.45%
Post-market: 73.710.00000.00%19:30 EDT
Volume:492.88K
Turnover:36.28M
Market Cap:3.37B
PE:64.14
High:74.01
Open:72.94
Low:72.67
Close:72.66
52wk High:78.25
52wk Low:46.30
Shares:45.76M
Float Shares:37.72M
Volume Ratio:1.07
T/O Rate:1.31%
Dividend:1.66
Dividend Rate:2.26%
EPS(TTM):1.15
EPS(LYR):-18.3696
ROE:3.99%
ROA:2.43%
PB:1.80
PE(LYR):-4.01

Loading ...

Ashland updates financial calendar with quarterly earnings release and analyst webcast

Reuters
·
Apr 16

Ashland (ASH) Gets a Hold from Wells Fargo

TIPRANKS
·
Apr 10

Ashland price target lowered to $65 from $70 at Mizuho

TIPRANKS
·
Apr 06

Mizuho Cuts Price Target on Ashland to $65 From $70, Keeps Outperform Rating

MT Newswires Live
·
Apr 06

U.S. RESEARCH ROUNDUP-EQT, Las Vegas Sands, Twilio

Reuters
·
Apr 06

Analysts Conflicted on These Materials Names: Ashland (ASH), Ivanhoe Mines (OtherIVPAF) and CMOC Group (OtherCMCLF)

TIPRANKS
·
Apr 05

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine

GlobeNewswire
·
Apr 02

United-Guardian FY2025 operating income drops to $2.2 million; net sales fall 13% to $10.5 million

Reuters
·
Mar 27

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

GlobeNewswire
·
Mar 27

Assessing Ashland (ASH) Valuation After Recent Share Price Weakness And Perceived 27.3% Discount

Simply Wall St.
·
Mar 24

Ashland Is Maintained at Buy by Argus Research

Dow Jones
·
Mar 23

Ashland Inc : Argus Research Cuts Target Price to $56 From $70

THOMSON REUTERS
·
Mar 23

Ashland Implements Pricing Actions Globally Due to Market Volatility Amid Middle East Conflict

MT Newswires Live
·
Mar 23

Ashland to implement global pricing actions across product portfolio to manage energy, raw material and logistics volatility

Reuters
·
Mar 23

Press Release: BioLineRx Reports 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

Ashland Inc - Pricing Actions to Vary by Product and Region

THOMSON REUTERS
·
Mar 23

Ashland Implements Pricing Actions Across Product Portfolio in Response to Market Volatility

THOMSON REUTERS
·
Mar 23

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

GlobeNewswire
·
Mar 20

Press Release: SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 20

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

prnewswire
·
Mar 19